Leukemia refers to a type of cancer that impacts your blood cells and bone marrow. Its the seventh most common cause of cancer-related deaths in the United States.
The outlook for leukemia can seem complicated to predict due to the different types of leukemia. Some leukemias are slow-growing (chronic), while others spread rapidly (acute). Also, each has varying symptoms and treatment options.
Read on to learn more about each of the major subtypes of leukemia so that you can better understand what treatment options are best for you.
There are four main types of leukemia, and each affects the blood cells in different ways. Chronic forms of leukemia tend to affect middle-aged to older adults, while acute versions mostly affect children and young adults.
CML starts in your bone marrow, creating an abnormally high number of unhealthy white blood cells known as granulocytes.
Also called chronic granulocytic (or myeloid) leukemia, CML is thought to be partially attributed to gene mutations called Philadelphia chromosomes.
This type of leukemia is most common in middle-aged adults and is rare in children. Its estimated that 15 percent of leukemia cases in adults are CML.
As CML progresses, granulocytes take over your bone marrow and blood so that theres no room for red blood cells, platelets, or healthy white blood cells.
Some of the initial symptoms include:
In some people, CML causes no symptoms at all.
One promising area of treatment for CML involves targeted therapies that treat abnormal mutations from the Philadelphia chromosome. Researchers have found that targeted therapies can help people with CML survive closer to a normal life expectancy.
CLL also occurs in the bone marrow, leading to the production of too many lymphocytes, another type of white blood cell.
Like CML, CLL tends to occur in middle-aged adults and is one of the most common types of adult-onset leukemia. CLL is also rare in children.
Unlike CML, CLL develops slowly. Some of the symptoms include:
You may not experience symptoms until CLL reaches a later phase.
HCL is a rare form of CLL that causes the same symptoms as CLL. Its called hairy cell because of the way the cancerous cells look under a microscope.
HCL is thought to occur mostly in older men, though the exact cause isnt known. Unlike other types of leukemia, HCL isnt defined by stages. Its also more difficult to treat, and may recur despite standard treatments.
Targeted therapies are also used in early CLL cases. Research has shown that combination therapies may be more effective compared to using one targeted therapy at one time.
Another potential future treatment may include the use of chimeric antigen receptor (CAR) T-cell therapy. This type of immunotherapy alters healthy cells in a way they may more effectively attack cancerous ones.
Researchers are also investigating the possibility of additional targeted therapies to help treat HCL.
AML occurs when there are abnormal white blood cells in your body called myeloblasts. This type of cancer is also called acute myelogenous, granulocytic, nonlymphocytic, or myeloblastic leukemia.
The most common form of acute (fast-developing) leukemia among adults, AML is also the most critical because it progresses rapidly. Some adults previously treated for acute lymphocytic leukemia (ALL) as children may develop AML later in life.
AML is most commonly treated with chemotherapy (with or without stem cells) and radiation therapy. Various targeted therapies are relatively new in the treatment of AML, and different combinations are being researched further.
Also known as acute lymphoblastic leukemia, ALL is responsible for creating too many lymphocytes. Unlike the chronic version of this cancer (CLL), ALL rapidly progresses if its left untreated. However, ALL may be easier to treat than AML.
Also, while CLL is more common in adults, ALL is more prevalent in children. However, certain risk factors may increase the risk of ALL in adults, such as being an adult white male over the age of 70.
CAR T-cell therapy is currently used in children and young adults with ALL. As with CLL, research is ongoing into the possibility of using CAR T-cells for older adults with this type of cancer.
The exact type of treatment depends on the stage and type of leukemia you have, as well as your age.
Targeted therapies are used in earlier phases of this cancer, while surgeries and stem cell transplants are used when other treatment options havent worked. Stem cell transplants are also more typically used in children.
Unlike other types of leukemia, both CLL and HCL treatment may include watchful waiting in early stages due to the slower rates of progression.
Both ALL and AML progress rapidly. Early treatment is important to help prevent further spread.
A leukemia diagnosis can be challenging to process for both you and your loved ones no matter which type you may have.
First, learn as much as you can about your cancer diagnosis. Talk with a doctor and ask them questions about treatment options and factors that affect your prognosis, which can vary between individuals.
Also, enlist the help of friends and loved ones for emotional support and assistance with daily tasks as you start cancer treatment.
For additional help, ask a doctor for local or virtual leukemia support groups. Such groups consist of individuals sharing similar experiences who may seek or offer advice while also helping you feel less alone.
Overall, the exact outlook for all types of leukemia depends on:
AML and ALL progress the most rapidly of all subtypes.
Its estimated that 1.5 percent of all Americans will develop leukemia in their lifetime. But the overall death rate continues to decline, thanks to developing treatments.
Because everyone responds to leukemia medications differently, its important to continue talking with a doctor about all of your options.
The exact treatment and prognosis for leukemia depends greatly on the type due to each ones differing effects on your blood cells. You may also need slower or more aggressive treatment depending on whether the case is chronic or acute.
Having friends and loved ones help you with anything you need as well as a support group to share your experiences and learn from other can help you prepare and cope with the next steps in your journey.
See more here:
4 Types of Leukemia: Symptoms, Treatments, and More - Healthline
- Biology of stem cells: an overview - PMC - National Center for ... - March 26th, 2024
- Iron Limitation Preserves Youthfulness of Blood Stem Cells - Mirage News - March 13th, 2024
- Mini organs grown from stem cells of unborn babies for the first time in breakthrough - The Mirror - March 9th, 2024
- The Effect of Short-Term NAD3 Supplementation on Circulating Adult Stem Cells in Healthy Individuals Aged 40-70 ... - Cureus - March 7th, 2024
- University of Liverpool Spin-Out Emerges, Pioneering Novel Adult Stem Cell-Based Therapies - India Education Diary - March 7th, 2024
- Scientists have used cells from fluid drawn during pregnancy to grow mini lungs and other organs - Yahoo News Canada - March 6th, 2024
- Japan approves new stem cell-based Alzheimer's therapy By Proactive Investors - Investing.com Australia - January 20th, 2024
- Cyberstalking pits Harvard professor against PubPeer Retraction ... - Retraction Watch - December 5th, 2023
- 10 functional health predictions for 2024, according to a doctor and ... - 1330 WFIN - December 5th, 2023
- See the Brain Like Never Before in This Gorgeous Art - Scientific American - December 5th, 2023
- Geron Announces Publication in The Lancet of Results from the ... - BioSpace - December 5th, 2023
- Stem cell injections could be the key to curing MS - Freethink - December 3rd, 2023
- Jaypirca (pirtobrutinib) Now Approved by U.S. FDA for the ... - Investors | Eli Lilly and Company - December 3rd, 2023
- Comparative Efficacy and Safety of Four JAK Inhibitors for ... - HealthDay - December 3rd, 2023
- City lights up for Francis on Anthony Nolan's birthday - Liverpool Express - December 3rd, 2023
- NOT-AR-23-022: Request for Information on Themes for the NIAMS ... - National Institutes of Health (.gov) - December 3rd, 2023
- December 2023: Intramural Papers of the Month - Environmental Factor Newsletter - December 1st, 2023
- CNA Explains: What is cord blood banking and why do parents do it? - CNA - December 1st, 2023
- Regulation of myogenesis and adipogenesis by the electromagnetic ... - Nature.com - December 1st, 2023
- The effects of vitamin K on bone health - News-Medical.Net - December 1st, 2023
- Dr Hurwitz on Ongoing Investigations of the Use of CAR T-Cell ... - OncLive - December 1st, 2023
- Mitophagy in human health, ageing and disease - Nature.com - December 1st, 2023
- Adult Stem Cells - Stem Cells and the Future of Regenerative Medicine ... - November 29th, 2023
- Navigating The Regulatory Landscape Of Longevity Health Products ... - Mondaq News Alerts - November 29th, 2023
- MS breakthrough could lead to treatments that halt disease's ... - inews - November 29th, 2023
- Reprogramming tissue mechanically to promote wound healing - Phys.org - November 29th, 2023
- Latest Advances in Arthritis Diagnosis and Treatment at American ... - HealthDay - November 29th, 2023
- Sex-associated differences in frequencies and prognostic impact of ... - Nature.com - November 29th, 2023
- Hematologists Dive into the Current Treatment Landscape - OncLive - November 29th, 2023
- Team discovers protein crucial for B cell differentiation and antibodies - Phys.org - November 29th, 2023
- Science Talk - I survived cancer as a child and now I'm working to ... - The Institute of Cancer Research - November 29th, 2023
- First Edition: Nov. 29, 2023 - KFF Health News - November 29th, 2023
- Symptoms: Unilateral Hearing Loss and Tinnitus : The Hearing Journal - LWW Journals - November 29th, 2023
- Mitigation of sepsis-induced acute lung injury by BMSCs | IJN - Dove Medical Press - November 29th, 2023
- A Case of a Constricted Vessel: The Impact of Acute Myeloid ... - Cureus - November 29th, 2023
- Mum brushed off fatigue after having baby but fall sparked deadly diagnosis - The Mirror - November 29th, 2023
- How heritable is the epigenome? - Drug Discovery News - November 29th, 2023
- The Blueprint of Regeneration: Scientists Discover How to Turn Stem Cells Fate - Revyuh - November 27th, 2023
- BrainStorm Cell Therapeutics Announces In-Person Meeting with ... - Marketscreener.com - November 27th, 2023
- Stem Cell Therapy Developed in Korea Begins Treatment for ... - PharmiWeb.com - November 25th, 2023
- COVID-19 Pandemic's Adverse Effect on Bone Health in Young ... - HealthDay - November 25th, 2023
- Sickle cell breakthrough - The Indian Express - November 25th, 2023
- Wall thickness analysis method for judging the degree of lower ... - Nature.com - November 25th, 2023
- Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference - Yahoo Finance - November 23rd, 2023
- Disease Transmission and Diagnosis of Zika Virus - Cureus - November 23rd, 2023
- Gene-editing therapy for sickle cell earns conditional approval in UK - Sickle Cell Disease News - November 23rd, 2023
- Stem Cell Therapy Developed in Korea Begins Treatment for ... - Newswire - November 21st, 2023
- Efficacy of ADSC-CM in Patients with Telogen Effluvium | SCCAA - Dove Medical Press - November 21st, 2023
- BrainStorm Cell Therapeutics Announces In-Person Meeting with ... - PR Newswire - November 21st, 2023
- The Impact of CAR T Cell Therapy on Managing R/R LBCL - OncLive - November 21st, 2023
- Mansour bin Zayed witnesses inauguration of ADSCC Bone Marrow Transplant & Cellular Therapy Congress 2023 - ZAWYA - November 21st, 2023
- Listeria: Who is most susceptible? What are the Symptoms? What ... - Food Poison Journal - November 21st, 2023
- Scope Of Issued Patents May Be Limited By Prosecution Estoppel ... - Mondaq News Alerts - November 21st, 2023
- Qrons Announces the Addition of Professor Shiri Navon-Venezia to ... - StreetInsider.com - November 21st, 2023
- Financially strapped Athersys raises $10.4M - cleveland.com - November 19th, 2023
- From the India Today archives (2010) | How stem cells can save your life - India Today - November 19th, 2023
- Inactivation of the tumor suppressor gene Apc synergizes with H ... - Science - November 19th, 2023
- The Origins of Multiple Myeloma and Why it Matters - HealthTree For AML - Acute Myeloid Leukemia - November 19th, 2023
- Treatment Considerations With TROP2-Targeted Therapy - OncLive - November 19th, 2023
- Athersys narrows loss, raises $10.4 million during third quarter to ... - The Business Journals - November 17th, 2023
- Who was Dolly the Sheep and what happened to her? The story of ... - BBC Countryfile Magazine - November 17th, 2023
- UK first to approve CRISPR treatment for diseases: what you need to ... - Nature.com - November 17th, 2023
- 1st sickle cell patient to be given therapy restoring fetal hemoglobin - Sickle Cell Disease News - November 15th, 2023
- Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates - Century - Benzinga - November 13th, 2023
- Century Therapeutics Appoints Brent Pfeiffenberger, Pharm.D., MBA, as Chief Executive Officer - Yahoo Finance - November 11th, 2023
- Century Therapeutics and FUJIFILM Cellular Dynamics Announce Licenses for the Development and Commercialization of iPSC-Derived Cell Therapies in... - November 11th, 2023
- AAO 2023: Paul Runge and his ROP treatments in the Ukraine - Modern Retina - November 11th, 2023
- The Evolutionary Reasons We Are Drawn To Horror Movies and ... - Slashdot - November 11th, 2023
- Century Therapeutics Reports Third Quarter 2023 Financial Results ... - GlobeNewswire - November 11th, 2023
- Century Therapeutics Reports Third Quarter 2023 Financial Results ... - StreetInsider.com - November 9th, 2023
- NYU Langone Health Performs World's First Whole-Eye & Partial ... - NYU Langone Health - November 9th, 2023
- BrainStorm to Announce Third Quarter 2023 Financial Results and ... - BioSpace - November 9th, 2023
- Can we cut cost and pain of IVF? Start-up CEO tries out own ... - Genetic Literacy Project - November 9th, 2023
- Jasper Therapeutics Reports Third Quarter 2023 Financial Results ... - BioSpace - November 9th, 2023
- Impaired neural stress resistance and loss of REST in bipolar ... - Nature.com - November 9th, 2023
- Functional genomics and systems biology in human neuroscience - Nature.com - November 9th, 2023
- Trial launched to test CAR T-cell therapy in dogs diagnosed with ... - EurekAlert - November 9th, 2023
- The-Gut's-Lasting-Impact-on-Severe-COVID-19-Immune-Response - Infectious Disease Special Edition - November 9th, 2023
- Emerging Cure for Sickle Cell on its Way to FDA Approval, Carries ... - Dallasweekly - November 7th, 2023
- The science works, but will we pay for it? - Irish Medical Times - November 7th, 2023
Recent Comments